Brain Stimulation and Hand Training in Children With Hemiparesis
Primary Purpose
Pediatric Hemiparesis
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Transcranial Direct Current Stimulation (tDCS)
Placebo Comparator
Sponsored by
About this trial
This is an interventional treatment trial for Pediatric Hemiparesis focused on measuring Cerebral Palsy, Hemiparesis, Stroke, Non-Invasive Brain Stimulation, Transcranial Direct Current Stimulation, Constraint-Induced Movement Therapy, Diffusion Tensor Imaging, Congenital Hemiparesis, Bimanual Therapy
Eligibility Criteria
Inclusion Criteria:
- Hemispheric Stroke or Periventricular Leukomalacia confirmed by most recent MRI or CT radiologic report with resultant congenital hemiparesis
- ≥ 10 degrees of active motion at the metacarpophalangeal joint
- Receptive language function to follow two-step commands as evidenced by performance on TOKEN test of intelligence
- No evidence of seizure activity within the last 2 years
- Presence of a motor evoked potential from at least the contralesional hemisphere if not both hemispheres
- Ages 8-21 years
- Able to give informed assent along with the informed consent of the legal guardian
- Children who have had surgeries, which may influence motor function eg- tendon transfer, will be included, yet surgical history will be documented and included in any publication within a participant characteristics table.
Exclusion Criteria:
- Metabolic Disorders
- Neoplasm
- Epilepsy
- Disorders of Cellular Migration and Proliferation
- Acquired Traumatic Brain Injury
- Pregnancy
- Indwelling metal or incompatible medical devices
- Evidence of skin disease or skin abnormalities
- Botulinum toxin or Phenol block within [six-months] preceding the study
Sites / Locations
- University of Minnesota
- Gillette Children's Specialty Healthcare
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Placebo Comparator
Arm Label
tDCS/CIMT
tDCS sham/CIMT
Arm Description
Intervention Group will receive 20 minutes of 1.0 mA tDCS to the contralesional hemisphere concurrent with CIMT.
Placebo Group will receive 20 minutes of sham 1.0 mA tDCS to the contralesional hemisphere concurrent with CIMT.
Outcomes
Primary Outcome Measures
Change in Assisting Hand Assessment (AHA)
Participants were videotaped while performing a bimanual age-appropriate activity. Investigators scored this performance using the Assessment of Assisting Hand (AHA) inventory. The AHA consists of 22 items, each scored on a 4-point scale. Raw scores are a sum of the 22 item scores, ranging from 22-88. Computer software logarithmically transforms ordinal raw scores into a final score. Final scores are reported on a logit-based AHA-unit scale and range from 0 to 100, with higher scores indicating greater ability. Outcome is reported as the change from baseline to 2 weeks and change from baseline to 6 months.
Secondary Outcome Measures
Change in Canadian Occupational Performance Measurement (COPM)
The COPM is clinician-administered semi-structured interview measuring the participant's perception of satisfaction and performance of personally set goals. There are 3 categories (Self-Care, Productivity, and Leisure) each containing 3 subcategories each for a total of 9 items, which are rated on an ordinal scale from 1 (minimum importance) to 10 (maximum importance). Each of the child's goals are given a satisfaction and performance rating. The average of the satisfaction ratings across all goals is reported as the "average satisfaction score", ranging from 1 to 10, with higher scores indicating a better outcome. Outcome is reported as the change from baseline to 2 weeks and change from baseline to 6 months.
Full Information
NCT ID
NCT02250092
First Posted
September 18, 2014
Last Updated
August 6, 2020
Sponsor
University of Minnesota
Collaborators
Cerebral Palsy International Research Foundation, Foundation for Physical Therapy, Inc., National Institutes of Health (NIH)
1. Study Identification
Unique Protocol Identification Number
NCT02250092
Brief Title
Brain Stimulation and Hand Training in Children With Hemiparesis
Official Title
Synergistic Effect of Combined Transcranial Direct Current Stimulation/Constraint Induced Movement Therapy in Children With Hemiparesis
Study Type
Interventional
2. Study Status
Record Verification Date
August 2020
Overall Recruitment Status
Completed
Study Start Date
December 31, 2014 (Actual)
Primary Completion Date
June 28, 2017 (Actual)
Study Completion Date
July 10, 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Minnesota
Collaborators
Cerebral Palsy International Research Foundation, Foundation for Physical Therapy, Inc., National Institutes of Health (NIH)
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Data Monitoring Committee
No
5. Study Description
Brief Summary
Hemiparetic cerebral palsy influences motor function in children during development and throughout their lifetime. The deficits one sees are the result both of the congenitally induced brain lesion and the subsequent plasticity that can impair function of the surviving neurons in the damaged brain.
Many current treatments have limited influence on children's neurorecovery. Constraint-induced movement therapy (CIMT) involving constraining the unaffected limb to encourage use of the affected limb has shown promise, yet with new technology revealing the potential to directly influence the brain, there is an urgent need to study the synergy of combined techniques.
Non-invasive brain stimulation (NIBS) as a direct neuromodulatory intervention has the potential to act synergistically with CIMT to influence neurorecovery.
Combining behavioral therapies, constraint-induced movement therapy (CIMT), with a novel form of neuromodulation, transcranial direct current stimulation (tDCS), we investigated the influence of this intervention on improved motor outcomes in children with cerebral palsy. The study hypotheses surround the safety, feasibility and efficacy of combined CIMT and tDCS wherein those children who receive the combined intervention will reveal no major adverse events, yet improved hand function and cortical excitability.
To Note: In addition to the combination of NIBS with CIMT, we also investigated the combination of NIBS with another form of motor intervention, bimanual, or two-handed, training. During bimanual training, children engage both hands in movements. The goal of bimanual training is to teach children how to most effectively use their hands cooperatively. During bimanual training, children play with games and toys that require the use of both hands. Children also practice activities of daily living that require the use of both hands, such as putting hair in a ponytail, tying shoes, and buttoning clothing. N=8 for this pilot study and no randomization. (Burke Medical Research Institute partnered with Columbia University and did a parallel pilot study. N=8 (PIs Friel and Gordon; Protocol BRC449)
Detailed Description
We use single-pulse transcranial magnetic stimulation (TMS) to measure the location and strength of brain connections that control hand movements.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pediatric Hemiparesis
Keywords
Cerebral Palsy, Hemiparesis, Stroke, Non-Invasive Brain Stimulation, Transcranial Direct Current Stimulation, Constraint-Induced Movement Therapy, Diffusion Tensor Imaging, Congenital Hemiparesis, Bimanual Therapy
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigator
Allocation
Randomized
Enrollment
20 (Actual)
8. Arms, Groups, and Interventions
Arm Title
tDCS/CIMT
Arm Type
Active Comparator
Arm Description
Intervention Group will receive 20 minutes of 1.0 mA tDCS to the contralesional hemisphere concurrent with CIMT.
Arm Title
tDCS sham/CIMT
Arm Type
Placebo Comparator
Arm Description
Placebo Group will receive 20 minutes of sham 1.0 mA tDCS to the contralesional hemisphere concurrent with CIMT.
Intervention Type
Device
Intervention Name(s)
Transcranial Direct Current Stimulation (tDCS)
Other Intervention Name(s)
tDCS, Brain Stimulation
Intervention Description
10 tDCS/CIMT Sessions
Intervention Type
Device
Intervention Name(s)
Placebo Comparator
Primary Outcome Measure Information:
Title
Change in Assisting Hand Assessment (AHA)
Description
Participants were videotaped while performing a bimanual age-appropriate activity. Investigators scored this performance using the Assessment of Assisting Hand (AHA) inventory. The AHA consists of 22 items, each scored on a 4-point scale. Raw scores are a sum of the 22 item scores, ranging from 22-88. Computer software logarithmically transforms ordinal raw scores into a final score. Final scores are reported on a logit-based AHA-unit scale and range from 0 to 100, with higher scores indicating greater ability. Outcome is reported as the change from baseline to 2 weeks and change from baseline to 6 months.
Time Frame
2 weeks, 6 months
Secondary Outcome Measure Information:
Title
Change in Canadian Occupational Performance Measurement (COPM)
Description
The COPM is clinician-administered semi-structured interview measuring the participant's perception of satisfaction and performance of personally set goals. There are 3 categories (Self-Care, Productivity, and Leisure) each containing 3 subcategories each for a total of 9 items, which are rated on an ordinal scale from 1 (minimum importance) to 10 (maximum importance). Each of the child's goals are given a satisfaction and performance rating. The average of the satisfaction ratings across all goals is reported as the "average satisfaction score", ranging from 1 to 10, with higher scores indicating a better outcome. Outcome is reported as the change from baseline to 2 weeks and change from baseline to 6 months.
Time Frame
2 weeks, 6 months
Other Pre-specified Outcome Measures:
Title
Change in Subject Symptom Assessment (SSA) From 2 Weeks to 6 Months
Description
The Subject Symptom Assessment (SSA) is a questionnaire of common side effects reported in the literature that is asked of the child undergoing non-invasive brain stimulation. This measure asks the child to rate if the symptom is present (yes or no) and if it is present, rate the severity using a 1 to 4 scale (1 indicates absent, 2=mild, 3=moderate, 4=severe). Lower values are better as they represent absent or mild symptoms. Outcome is reported as the change in symptom severity from 2 weeks of treatment to 6 months of treatment. This measure is not collected at baseline.
Time Frame
2 weeks, 6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
8 Years
Maximum Age & Unit of Time
21 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Hemispheric Stroke or Periventricular Leukomalacia confirmed by most recent MRI or CT radiologic report with resultant congenital hemiparesis
≥ 10 degrees of active motion at the metacarpophalangeal joint
Receptive language function to follow two-step commands as evidenced by performance on TOKEN test of intelligence
No evidence of seizure activity within the last 2 years
Presence of a motor evoked potential from at least the contralesional hemisphere if not both hemispheres
Ages 8-21 years
Able to give informed assent along with the informed consent of the legal guardian
Children who have had surgeries, which may influence motor function eg- tendon transfer, will be included, yet surgical history will be documented and included in any publication within a participant characteristics table.
Exclusion Criteria:
Metabolic Disorders
Neoplasm
Epilepsy
Disorders of Cellular Migration and Proliferation
Acquired Traumatic Brain Injury
Pregnancy
Indwelling metal or incompatible medical devices
Evidence of skin disease or skin abnormalities
Botulinum toxin or Phenol block within [six-months] preceding the study
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Bernadette T Gillick, PhD, MSPT, PT
Organizational Affiliation
University of Minnesota
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Minnesota
City
Minneapolis
State/Province
Minnesota
ZIP/Postal Code
55455
Country
United States
Facility Name
Gillette Children's Specialty Healthcare
City
Saint Paul
State/Province
Minnesota
ZIP/Postal Code
55101
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
26558386
Citation
Gillick B, Menk J, Mueller B, Meekins G, Krach LE, Feyma T, Rudser K. Synergistic effect of combined transcranial direct current stimulation/constraint-induced movement therapy in children and young adults with hemiparesis: study protocol. BMC Pediatr. 2015 Nov 12;15:178. doi: 10.1186/s12887-015-0498-1.
Results Reference
background
PubMed Identifier
30471965
Citation
Lixandrao MC, Stinear JW, Rich T, Chen CY, Feyma T, Meekins GD, Gillick BT. EMG breakthrough during cortical silent period in congenital hemiparesis: a descriptive case series. Braz J Phys Ther. 2020 Jan-Feb;24(1):20-29. doi: 10.1016/j.bjpt.2018.11.002. Epub 2018 Nov 22.
Results Reference
derived
Learn more about this trial
Brain Stimulation and Hand Training in Children With Hemiparesis
We'll reach out to this number within 24 hrs